Cargando…
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
Reduction of the risk of asthma attacks is a major goal of current asthma management. We propose to derive a risk scale predicting asthma attacks based on the blood eosinophil count and exhaled nitric oxide (FeNO). Biomarker-stratified trial-level attack rates were extracted and pooled from the cont...
Autores principales: | Couillard, Simon, Laugerud, Annette, Jabeen, Maisha, Ramakrishnan, Sanjay, Melhorn, James, Hinks, Timothy, Pavord, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762000/ https://www.ncbi.nlm.nih.gov/pubmed/34362839 http://dx.doi.org/10.1136/thoraxjnl-2021-217325 |
Ejemplares similares
-
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
por: Howell, Imran, et al.
Publicado: (2023) -
Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling
por: Couillard, Simon, et al.
Publicado: (2022) -
Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020) -
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
por: Couillard, Simon, et al.
Publicado: (2021) -
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
por: Price, David B., et al.
Publicado: (2019)